There was again no difference in the expression of cyclins or in the effect of AZD5363 on this expression between CLL samples that were responsive or unresponsive to the anti-proliferative effects of AKT inhibition. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.